Prothena Plc Stock Today
| PRTA Stock | USD 23.54 0.20 0.84% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Prothena Plc is trading at 23.54 as of the 8th of May 2024, a -0.84 percent decrease since the beginning of the trading day. The stock's open price was 23.74. Prothena Plc has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Prothena plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of May 2022 and ending today, the 8th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 21st of December 2012 | Category Healthcare | Classification Health Care |
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company was founded in 2012 and is based in Dublin, Ireland. Prothena Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 53.72 M outstanding shares of which 6.63 M shares are at this time shorted by private and institutional investors with about 10.63 trading days to cover. More on Prothena plc
Moving together with Prothena Stock
| 0.66 | XCUR | Exicure | PairCorr |
| 0.9 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Prothena Stock
| 0.64 | IMNN | Imunon Inc Financial Report 9th of May 2024 | PairCorr |
| 0.53 | ELYM | Eliem Therapeutics Trending | PairCorr |
| 0.41 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Prothena Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Prothena Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Prothena Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Prothena Plc report their recommendations after researching Prothena Plc's financial statements, talking to executives and customers, or listening in on Prothena Plc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Prothena plc. The Prothena consensus assessment is calculated by taking the average forecast from all of the analysts covering Prothena Plc. | |||||
Prothena Plc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Prothena Plc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Prothena Plc's financial leverage. It provides some insight into what part of Prothena Plc's total assets is financed by creditors.
| |||||
Prothena plc (PRTA) is traded on NASDAQ Exchange in USA. It is located in 77 Sir John Rogerson?s Quay, Dublin, Ireland, D02 VK60 and employs 173 people. Prothena Plc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prothena Plc's market, we take the total number of its shares issued and multiply it by Prothena Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Prothena plc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 53.72 M outstanding shares of which 6.63 M shares are at this time shorted by private and institutional investors with about 10.63 trading days to cover.
Prothena plc currently holds about 508.8 M in cash with (133.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.84.
Check Prothena Plc Probability Of Bankruptcy
Ownership AllocationProthena plc has a total of 53.72 Million outstanding shares. The majority of Prothena plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Prothena plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Prothena Plc. Please pay attention to any change in the institutional holdings of Prothena plc as this could imply that something significant has changed or is about to change at the company. Also note that almost six million four hundred fourty-six thousand four hundred sixty invesors are currently shorting Prothena Plc expressing very little confidence in its future performance.
Check Prothena Ownership Details
Prothena Stock Price Odds Analysis
What are Prothena Plc's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Prothena Plc jumping above the current price in 90 days from now is about 72.37%. The Prothena plc probability density function shows the probability of Prothena Plc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.0158 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Prothena Plc will likely underperform. Additionally, prothena plc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Prothena Plc to move above the current price in 90 days from now is about 72.37 (This Prothena plc probability density function shows the probability of Prothena Stock to fall within a particular range of prices over 90 days) .
Prothena Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Prothena Plc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Prothena Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Prothena Plc's value.| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 867.6 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 667.6 K | |
| Boxer Capital Llc | 2023-12-31 | 665 K | |
| Rock Springs Capital Management Lp | 2023-12-31 | 625 K | |
| Artal Group S A | 2023-12-31 | 501.4 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 482.3 K | |
| Eventide Asset Management, Llc | 2023-12-31 | 445.2 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 442.3 K | |
| Granahan Investment Management Inc.. | 2023-12-31 | 417.2 K | |
| Ecor1 Capital, Llc | 2023-12-31 | 11.6 M | |
| Fmr Inc | 2023-12-31 | 8 M |
Prothena Plc Historical Income Statement
Prothena plc Income Statement is one of the three primary financial statements used for reporting Prothena's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Prothena plc revenue and expense. Prothena Plc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Prothena Plc's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 95.9 M, whereas Depreciation And Amortization is forecasted to decline to about 881.6 K. View More FundamentalsProthena Stock Against Markets
Picking the right benchmark for Prothena Plc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Prothena Plc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Prothena Plc is critical whether you are bullish or bearish towards Prothena plc at a given time. Please also check how Prothena Plc's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Prothena Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Prothena Plc Corporate Management
Elected by the shareholders, the Prothena Plc's board of directors comprises two types of representatives: Prothena Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Prothena. The board's role is to monitor Prothena Plc's management team and ensure that shareholders' interests are well served. Prothena Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Prothena Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hideki MD | Chief Officer | Profile | |
| CPA CPA | Chief Controller | Profile | |
| Jennifer Zibuda | Director Communication | Profile | |
| Brandon Smith | Chief Officer | Profile | |
| Wagner Zago | Chief Scientific Officer | Profile | |
| Carol Karp | Chief Regulatory Officer | Profile | |
| David Ford | Chief Officer | Profile |
How to buy Prothena Stock?
Before investing in Prothena Plc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Prothena Plc. To buy Prothena Plc stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Prothena Plc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Prothena Plc stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Prothena plc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Prothena plc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Prothena plc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Prothena Stock please use our How to Invest in Prothena Plc guide.
Already Invested in Prothena plc?
The danger of trading Prothena plc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Prothena Plc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Prothena Plc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Prothena plc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Prothena Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.76) | Revenue Per Share 1.717 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.25) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.